In France, more than 20,000 new cases are diagnosed each year. A high figure, and yet a disease that remains in the shadows. On the occasion of Bladder Month, doctors and associations are sounding the alarm: better information already means saving lives.
A visible symptom… but still too often ignored
There are signs that the body sends directly. In the case of bladder cancer, the message is clear, visible, sometimes brutal: blood in the urine. And yet, this signal is still too often trivialized.
In 80 to 90% of cases, this is the first symptom. A simple, identifiable indicator – but which many attribute to a temporary infection or prefer to ignore out of embarrassment or fear.
“Bladder cancer today remains largely unknown to the general public, even though there is a warning sign visible in the majority of cases. The whole point is to make people understand that this symptom should never be ignored. Seeing blood in your urine, even once, should prompt you to seek medical help quickly. It’s a simple but decisive reflex, because early diagnosis radically changes the prognosis.” declares Professor Yann Neuzillet, urologist and vice-president of the French Association of Urology
This delay in consulting is not without consequences. Because in this disease, time plays a decisive role. If diagnosed early, cancer can be treated effectively. But when he progresses in silence, the outlook quickly darkens.
With nearly 20,000 new cases per year in France, it is the second urological cancer in men. And despite this frequency, awareness among the general public remains low.
The transition is brutal: from a visible symptom to a disease that is sometimes already advanced at the time of diagnosis. This is where a large part of the fight takes place.
The weight of diagnosis: between urgency and inequalities in the face of illness
Behind each diagnosis, a switch. That of an ordinary life towards an often long, sometimes heavy care journey.
Bladder cancer has a striking feature: its prognosis varies considerably depending on when it is detected. Taken at an early stage, the five-year survival rate exceeds 80%. But it drops to around 50% when the disease is more advanced, and up to 5% in cases of metastases. A dizzying gap, which reflects a simple reality: consulting early can change everything.
© AFU
The journey generally begins with the general practitioner, then continues with the urologist. Imaging tests, bladder fibroscopy, sometimes natural surgery… each step aims to understand, then act quickly.
In about 75% of cases, the tumor has not yet invaded the bladder muscle. A situation that allows conservative treatments, with close monitoring.
But for more advanced forms, the treatments become heavier: chemotherapy, surgery, sometimes radiotherapy.
Beyond the medical aspect, the illness also imposes an intimate upheaval. Urinary problems, fatigue, anxiety… Daily life is profoundly affected.
Supportive care then takes on its full importance. They do not cure, but accompany. They help maintain quality of life, preserve autonomy, and rebuild a form of normality.
Gradually, another story emerges: that of medical advances, bringing hope.
Major progress, and the hope of less invasive medicine
In recent years, research has profoundly transformed the management of bladder cancer. Immunotherapies, conjugated antibodies, targeted treatments: innovations are multiplying and changing the situation, particularly for advanced forms of the disease. Certain therapeutic combinations now make it possible to halve the risk of death in patients with advanced or metastatic forms.
“Therapeutic advances in bladder cancer are major today and are profoundly transforming patient care. We now have more effective treatments, sometimes earlier, which not only improve survival, but also allow us to consider less invasive approaches. The challenge now is to accelerate their access for all patients and to continue to structure clear care pathways, in which the urologist retains a central role.”
declares Dr Benjamin Pradère, urologist, member of the AFU oncology committee.
One of the great hopes rests precisely on this idea: treating differently. Avoid, when possible, major surgeries such as removal of the bladder. Preserve the body, self-image, quality of life.
Research is underway on urinary biomarkers, which could ultimately limit invasive examinations. Others are exploring treatments administered earlier that can avoid surgery if the response is complete. This movement towards more personalized, gentler medicine, more respectful of the patient, draws a new perspective. But this progress only takes on its full meaning if it is accessible. However, even today, certain innovations are slow to be available to everyone in France.
Collective vigilance to be built
Bladder cancer is not a rare disease. It is also not invisible. But it too often remains silent in people’s minds. Inform, remove taboos, encourage rapid consultation: these simple actions can save lives. Because ultimately, it all starts with paying attention to yourself. A different look at a symptom. A decision to consult, without delay.
In this disease, more than in many others, the story can change in an instant. A moment when we choose not to look away.